Skip to content

Latest

Mylan, Dr. Reddy’s launch Zyprexa generics

Mylan Inc. and Dr. Reddy’s Laboratories have released olanzapine tablets, an antipsychotic medication, in six dosage strengths. The companies said Tuesday that their products, a generic version of Zyprexa from Eli Lilly and Co., come in strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg. Dr.

Pharmacies see setback in case against PBM merger

A federal judge has denied an effort by retail pharmacy groups to prevent pharmacy benefit managers Express Scripts Inc. and Medco Health Solutions Inc. from merging. Published reports said Judge Cathy Bissoon of the U.S.

NACDS bestows top honors to Katz’s Giancamilli, Unilever’s Brown

The National Association of Chain Drug Stores has recognized Andy Giancamilli, former chief executive officer of Katz Group Canada, with the Sheldon W. Fantle Lifetime Achievement Award and M. Jerome Brown, former vice president of industry and customer development at Unilever, with the Robert B.

NABP: Online drug sellers shirk U.S. Rx laws

Well over 90% of Internet drug outlets don’t comply with U.S. pharmacy laws, in turn driving prescription drug abuse and misuse and facilitating the entry of counterfeit medications into the U.S. drug supply, a study by the National Association of Boards of Pharmacy (NABP) found.

NCPA gives take on PDUFA reauthorization

The National Community Pharmacists Association has submitted recommendations to federal lawmakers as a Senate committee readies legislation to reauthorize the Prescription Drug User Fee Act (PDUFA). NCPA said it has sent a letter to Sen. Tom Harkin (D.

BioScrip appoints chief financial officer

BioScrip Inc. has named Hai Tran as senior vice president, chief financial officer and treasurer. The company said late Monday that Tran is slated to take over the CFO post on May 14 from Mary Jane Graves, who has been serving as interim CFO and treasurer since January 2011. Plans call for MJ

Bud Light Lime adds ‘Lime-A-Rita’

Anheuser-Busch is expanding its Bud Light lineup with Bud Light Lime Lime-a-Rita, which the company said gives a fresh twist to a classic summer cocktail, the margarita. Bud Light Lime also now sports new packaging.

AstraZeneca to acquire Ardea Biosciences

AstraZeneca plans to buy Ardea Biosciences Inc. in a cash deal valued at $1.26 billion. The companies said Monday that they expect the transaction to close in the second or third quarter of this year. The clinically most advanced product candidate of Ardea, a San Diego-based biotech firm focused on